Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 1,785 Shares

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 1,785 shares of the company’s stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $26.98, for a total transaction of $48,159.30. Following the completion of the transaction, the chief operating officer now directly owns 768,208 shares of the company’s stock, valued at $20,726,251.84. This represents a 0.23 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Evan Roberts also recently made the following trade(s):

• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The stock was sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total value of $76,450.53.

Phreesia Stock Performance

NYSE:PHR opened at $27.24 on Monday. The firm has a market capitalization of $1.58 billion, a PE ratio of -18.53 and a beta of 0.94. The stock’s fifty day moving average is $23.54 and its 200 day moving average is $22.83. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $29.16. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Phreesia (NYSE:PHR) last announced its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same quarter in the prior year, the firm posted ($0.58) earnings per share. The business’s revenue for the quarter was up 16.6% on a year-over-year basis. On average, sell-side analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Citigroup increased their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research note on Friday, January 10th. Truist Financial raised their price objective on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and increased their price target for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Finally, KeyCorp raised their price target on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Phreesia currently has an average rating of “Buy” and a consensus price target of $31.00.

Institutional Trading of Phreesia

Several institutional investors have recently added to or reduced their stakes in PHR. Versor Investments LP bought a new position in shares of Phreesia during the third quarter valued at approximately $694,000. Zacks Investment Management bought a new position in Phreesia in the 3rd quarter valued at $631,000. Sei Investments Co. grew its position in Phreesia by 135.3% in the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after acquiring an additional 95,058 shares during the last quarter. State Street Corp increased its stake in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares during the period. Finally, Franklin Resources Inc. lifted its position in shares of Phreesia by 3.0% during the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after purchasing an additional 42,973 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.